Yeji
FDA approvalconf 0.95

cysteine hydrochloride — FDA approval

$ETON · Eton Pharmaceuticals, Inc.
Event date
April 11, 2022
1517 days ago
Sponsor runway
cash-flow +
$19.7M liquid

Evidence

Eton Pharmaceuticals, Inc. announced that it has received final approval from the U.S. Food and Drug Administration ("FDA") for its cysteine hydrochloride abbreviated new drug application ("ANDA").
Source: 8-K filed 2022-04-11View on EDGAR ↗0001493152-22-009540

Comparable historical fda approvals· last 5 years · same event type

100% hit rate (10/10)
TickerDrugDateOutcome
$INCYzynyz2026-05-18success
$INCYjakafi xr2026-05-01success
$AXSMauvelity2026-04-30success
$INCYzynyz2026-03-30success
$BIIBspinraza2026-03-27success
$CORTlifyorli2026-03-25success
$RYTMimcivree2026-03-19success
$ASNDyuviwel2026-02-27success
$BMRNpalynziq2026-02-27success
$ETONdesmoda2026-02-25success

Recent insider activity· ±90 days

6 insiders · 0 buys · 0 sells
Grant
2022-02-07
CASAMENTO CHARLES J
Director
50,000 @
Grant
2022-02-07
Adams Jennifer McKie
Director
50,000 @
Grant
2022-02-07
MAIER PAUL V
Director
50,000 @
Grant
2022-02-07
BRYNJELSEN SEAN
President & CEO
416,500 @
Grant
2022-02-07
Troutman William Wilson
CFO and Secretary
15,000 @
Grant
2022-02-07
RIEDEL NORBERT G
Director
50,000 @